REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Farmasi Al Arif Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Farmasi Al Arif Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Farmasi Al Arif Sdn. Bhd. is based in Malaysia, with the head office in Kajang. The enterprise operates in the Pharmacies and Drug Stores industry. It was first established on September 04, 2019. The company’s latest financial report indicates a net sales revenue increase of 37.67% in 2022. Its’ total assets recorded a growth of 46.62%.

Headquarters
No. 9-G & 9-1, Jalan Awani Bangi 1/1, Taman Awani Bangi
Kajang; Selangor; Postal Code: 43000

Contact Details: Purchase the Farmasi Al Arif Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Farmasi Al Arif Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Farmasi Al Arif Sdn. Bhd. report to view the information.
Incorporation Date:
September 04, 2019
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
49%
Subsidiaries
Farmasi Duyong Sdn. Bhd.
60%
Company Performance
Financial values in the chart are available after Farmasi Al Arif Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
37.67%▲
Total operating revenue
37.67%▲
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
46.62%▲
Total equity
35.6%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-9.16%▼
Quick Ratio
-0.21%▼
Cash Ratio
-0.01%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo